Dialysis News and Research RSS Feed - Dialysis News and Research

When your kidneys are healthy, they clean your blood. They also make hormones that keep your bones strong and your blood healthy. When your kidneys fail, you need treatment to replace the work your kidneys used to do. Unless you have a kidney transplant, you will need a treatment called dialysis.

There are two main types of dialysis: hemodialysis and peritoneal dialysis. Both types filter your blood to rid your body of harmful wastes, extra salt and water. Hemodialysis does that with a machine. Peritoneal dialysis uses the lining of your abdomen, called the peritoneal membrane, to filter your blood. Each type has both risks and benefits. They also require that you follow a special diet. Your doctor can help you decide the best type of dialysis for you.
Diets high in animal proteins can worsen progression of kidney disease

Diets high in animal proteins can worsen progression of kidney disease

An estimated 26 million people in the United States have chronic kidney disease, which can lead to complete kidney failure. Once the kidneys fail, patients either need to undergo dialysis treatments three times a week or have a kidney transplant to remain alive. [More]
Study results pave way for new clinical trial for glioblastoma patients

Study results pave way for new clinical trial for glioblastoma patients

Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research. [More]
Elsevier chosen to publish ISN's Kidney International and Kidney International Supplements journals

Elsevier chosen to publish ISN's Kidney International and Kidney International Supplements journals

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the International Society of Nephrology, the global medical society devoted to advancing kidney care worldwide, announced today that Elsevier will publish ISN's flagship journals, Kidney International and Kidney International Supplements, as of January 1, 2016. [More]
Elsevier to publish ISN's flagship journals, Kidney International and Kidney International Supplements

Elsevier to publish ISN's flagship journals, Kidney International and Kidney International Supplements

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the International Society of Nephrology (ISN), the global medical society devoted to advancing kidney care worldwide, announced today that Elsevier will publish ISN's flagship journals, Kidney International and Kidney International Supplements, as of January 1, 2016. [More]
MJC ICM works out general guidelines for intensive care medicine

MJC ICM works out general guidelines for intensive care medicine

Frankfurt-based intensive care medical practitioner, Kai Zacharowski, is working on a joint curriculum for Europe. [More]
DaVita HealthCare Partners announces financial results for fourth quarter 2014

DaVita HealthCare Partners announces financial results for fourth quarter 2014

DaVita HealthCare Partners Inc. today announced results for the quarter and year ended December 31, 2014. Income from continuing operations attributable to DaVita HealthCare Partners Inc. for the quarter and year ended December 31, 2014 was $208 million and $723 million, or $0.96 and $3.33 per share, respectively. [More]
Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Astute Medical, Inc., developer of the NephroCheck® Test, today previewed the upcoming AKI & CRRT 2015 conference to be held in San Diego from February 17 to February 20. [More]
New article assesses 40 years of intensive effort to improve end-of-life care

New article assesses 40 years of intensive effort to improve end-of-life care

After four decades of work - first on patients' rights, then on family and caregiving relationships, and most recently on systemic reform -- we now know that it will take additional efforts in all three areas to improve care at the end of life, concludes an article in the New England Journal of Medicine. [More]
Davita Kidney Care exceeds its own previous immunization rates for dialysis patients, teammates

Davita Kidney Care exceeds its own previous immunization rates for dialysis patients, teammates

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company is a leader in immunizations for kidney care providers and has exceeded its own previous immunization rates for both dialysis patients and teammates. [More]
Winners of Verizon Powerful Answers Award bring solutions to redefine the world

Winners of Verizon Powerful Answers Award bring solutions to redefine the world

Four great ideas were named first place winners of the Verizon Powerful Answers Award, a year-long global challenge to discover and help bring to market technology-based solutions with the potential to change our world. [More]

Centura Health, DaVita HealthCare Partners jointly unveil FullWell

Centura Health and DaVita HealthCare Partners today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas. [More]
Researchers reveal key factor in understanding elevated cancer risk linked to gene therapy

Researchers reveal key factor in understanding elevated cancer risk linked to gene therapy

National Institutes of Health researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy. They conducted research on mice with a rare disease similar to one in humans, hoping their findings may eventually help improve gene therapy for humans. Researchers at the National Human Genome Research Institute, part of NIH, published their research in the Jan. 20, 2015, online issue of the Journal of Clinical Investigation. [More]
DaVita Rx celebrates ten years of service

DaVita Rx celebrates ten years of service

DaVita Rx, a full-service pharmacy created for patients with chronic conditions such as those with kidney disease, is celebrating a decade of accomplishments as an integrated pharmacy for patients with complex conditions across the country. [More]
Urinary levels of novel biomarkers linked to adverse long-term outcomes in AKI patients

Urinary levels of novel biomarkers linked to adverse long-term outcomes in AKI patients

High levels of two novel urinary biomarkers early in critical illness are associated with adverse long-term outcomes in patients with acute kidney injury (AKI), according to an international, multi-center study led by University of Pittsburgh School of Medicine Researchers. [More]
Dallas Cowboys timekeeper ready to get back to work after kidney transplant at UT Southwestern

Dallas Cowboys timekeeper ready to get back to work after kidney transplant at UT Southwestern

Jim Ely tackles life like Mean Joe Greene tackled running backs. A banker, he also worked weekends as a football referee for 38 years and still, at age 83, works as home-game timekeeper for the Dallas Cowboys. [More]
Quanta obtains CE mark for portable, cartridge-based haemodialysis system

Quanta obtains CE mark for portable, cartridge-based haemodialysis system

Quanta Fluid Solutions Ltd, a pioneering developer of advanced haemodialysis systems, announces it has received the CE mark for SC+, its portable, cartridge-based haemodialysis system. [More]
CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, announced today the first signed Middle East sales/distribution agreement for lead product Neutrolin with distributor Arabian Trade House in the Kingdom of Saudi Arabia. [More]

DaVita HealthCare Partners teammates provide new shoes to children

DaVita HealthCare Partners Inc. (NYSE: DVA), a leading provider of kidney care and health care services, today announced that its teammates once again partnered with U.S. charity Shoes That Fit to provide nearly 11,500 pairs of new shoes to children in need through a company-wide initiative called "Shoes-a-palooza." [More]
Keryx Biopharmaceuticals supplies AURYXIA tablets to wholesalers in US

Keryx Biopharmaceuticals supplies AURYXIA tablets to wholesalers in US

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") today announced it has begun shipping AURYXIA™ (ferric citrate) tablets to wholesalers in the U.S. Auryxia is approved for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis. [More]
Experimental drug warrants clinical study for treatment of Ebola infection

Experimental drug warrants clinical study for treatment of Ebola infection

A case report, published in The Lancet today, describes the successful treatment of Ebola using a new drug under clinical development for vascular leakage (FX06, a fibrin-derived peptide). [More]